A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : EP / estrogen-progesterone

[Related PubMed/MEDLINE]
Total Number of Papers: 46
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   EP  (>> Co-occurring Abbreviation)
Long Form:   estrogen-progesterone
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2017 Estrogen-progestin use and breast cancer characteristics in lean and overweight postmenopausal women. BMI, CI, OR
2016 Human Endometrial Exosomes Contain Hormone-Specific Cargo Modulating Trophoblast Adhesive Capacity: Insights into Endometrial-Embryo Interactions. EXOs, FAK
2015 Histopathological alterations during breast carcinogenesis in a rat model induced by 7,12-Dimethylbenz (a) anthracene and estrogen-progestogen combinations. BC, DMBA, HE, SD
2013 Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France. MHT
2011 Variation of seizure frequency with ovulatory status of menstrual cycles. ADSF
2010 Ovarian steroids, mitogen-activated protein kinases, and/or aspartic proteinases cooperate to control endometrial remodeling by regulating gene expression in the stroma and glands. ---
2010 Recent breast cancer incidence trends according to hormone therapy use: the California Teachers Study cohort. CI, HT
2009 Metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 ectodomain decreases endocytic clearance of endometrial matrix metalloproteinase-2 and -9 at menstruation. ADAM, LRP, MMP, RAP, TIMP
2009 [Effectiveness of bisphosphonate administration during Gn-RH agonist therapy for endometriosis]. BMD
10  2008 Activation of SRC kinase and phosphorylation of signal transducer and activator of transcription-5 are required for decidual transformation of human endometrial stromal cells. Ad-EGFP, HESCs, STAT
11  2008 Hormone therapy and ovarian cancer: incidence and survival. CI, E-alone, HT
12  2008 Prediagnostic use of hormone therapy and mortality after breast cancer. ---
13  2007 Declines in breast cancer after the WHI: apparent impact of hormone therapy. HT
14  2007 Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women. CRC, MSI, OR, PMH
15  2007 The effects of sex steroid replacement therapy on an expanded panel of IGF-related peptides. EA
16  2007 The EMAS 2006/2007 update on clinical recommendations on postmenopausal hormone therapy. HT
17  2006 Sex and ovarian steroids modulate brain-derived neurotrophic factor (BDNF) protein levels in rat hippocampus under stressful and non-stressful conditions. BDNF, DG, ELISA
18  2006 Updating the EMAS 2004/2005 clinical recommendations on postmenopausal therapy following the recent publications: WHI and Nurses' Health Study. ---
19  2005 Baseline associations between postmenopausal hormone therapy and inflammatory, haemostatic, and lipid biomarkers of coronary heart disease. The Women's Health Initiative Observational Study. CHD, CRP, IL-6, PHT, t-PA antigen
20  2005 Effects of gender on the severity of sepsis. IM
21  2004 Effect of estradiol and progesterone treatment on carbohydrate metabolizing enzymes in tissues of aging female rats. G6P'tase, G6PDH, HK
22  2003 Estradiol plus progesterone treatment modulates select elements of the proinflammatory cytokine cascade in steers: attenuated nitric oxide and thromboxane B2 production in endotoxemia. PRC, TNF, TXB
23  2001 Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats. ET-1
24  2000 Reduced growth of calves and its reversal by use of anabolic agents. GH
25  1999 Effect of an aproteic diet on gonadotropin release response to GnRH and estrogen-progesterone in rats. AP
26  1997 Hormonal modulation of the physiologic responses of calves infected with Eimeria bovis. PID
27  1996 Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris. EE, FAI, SHBG
28  1996 Estrogen modifies the baroreceptor-induced responses of supraoptic vasopressin neurons in the ovariectomized rat. SON
29  1995 Effect of ovarian hormones on the hypothalamic excitatory amino acids system during sexual maturation in female rats. APOA-MBH, Asp, EAAs, Glu, Gly, Tau
30  1995 Hypothalamic excitatory amino acid system during sexual maturation in female rats. EAAs
31  1993 Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women: effects of menopause and estrogen/progesterone therapy. IL-1, IL-1ra
32  1992 Effects of ovarian steroids on the gonadotropin response to N-methyl-D-aspartate and on hypothalamic excitatory amino acid levels during sexual maturation in female rats. NMDA
33  1990 Sexual maturation modifies the catecholaminergic control of gonadotrophin secretion and the effect of ovarian hormones on hypothalamic neurotransmitters in female rats. 5-HIAA, AH-POA, alpha-MT, DA, NE
34  1989 Effects of H1 and H2 histamine receptor antagonists on positive feed-back effect of estrogen on LH in prepubertal female rats. ---
35  1987 A1 noradrenergic input to medial preoptic-medial septal area: an electrophysiological study. ARC/ME, LHRH, MPO-S, OD comp
36  1987 Effect of gonadectomy and reposition of gonadal steroids on alpha-melanocyte-stimulating hormone concentration in discrete hypothalamic areas during a 24-hour period. alpha-MSH, MBH, POA
37  1986 Epidemiological data, cytology and colposcopy in IUD (intrauterine device), E-P (estro-progestogens) and diaphragm users. Study of cytological changes of endometrium IUD related. ---
38  1986 Suppression of receptive and proceptive behavior in ovariectomized, estrogen-progesterone-primed rats by intraventricular beta-endorphin: studies of behavioral specificity. beta-END, i.c.v
39  1985 Effect of the serotoninergic system on luteinizing hormone secretion in prepubertal female rats. 5-HTP, LH, PCA
40  1983 Effects of estradiol and progesterone on uterine prostaglandin levels in the pregnant rat. 6KF, PGF, TXB2
41  1983 Evidence for prolactin-releasing and release-inhibiting effects of melatonin, serotonin and arginine vasotocin. AVT, PRL, SO
42  1982 Enhanced and reversed growth in vitro of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by a gonadotropin-releasing hormone agonist analog. GnRH, PI
43  1982 Inhibition of lordosis behavior in the female rat by intraventricular infusion of prolactin and by chronic hyperprolactinemia. ACTH, PRL
44  1978 Effects of melatonin and natural and synthetic analogues of arginine vasotocin on plasma prolactin levels in adult male rats. AVT
45  1976 Dose-dependent prolactin releasing activity of arginine vasotocin in intact and pinealectomized estrogen-progesterone treated adult male rats. AVT
46  1975 Prolactin-releasing activity of arginine vasotocin in vitro. AVT, LH, LRH